Teleflex - TFX Enterprise Value-to-Revenue Multiple

Teleflex Inc. (TFX) - corporate logo

High patent barriers and FDA certification protect Teleflex Incorporated (TFX) from new entrants. However, pricing pressure from clinics and strict regulatory oversight create certain financial risks. Business resilience relies on critical resuscitation solutions that have become medical standards. Changes in the EV/Sales valuation reflect market expectations, with the current level standing at 3466.60.

TFX: Teleflex Inc. Company Value to Revenue 11/23/2025 - 11/19/2026

Financial and market metric breakdowns for Teleflex (TFX)

- market value and analyst target forecast:
Fundamental company valuation:TFX, teleflex.com
Original product of teleflex.com

This indicator measures the total enterprise value relative to revenue, excluding the impact of debt load to provide an objective assessment of operational efficiency. The stability of the EV/Sales ratio confirms the ability of Teleflex Incorporated (TFX) to maintain a high capitalization due to surgeons' exceptional reliance on specialized equipment, allowing the company to effectively monetize customer loyalty through premium pricing on consumables.

Competitor analysis

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient MMSI (Merit Medical Systems, Inc.)|NVST - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio ICU Medical Corp ICUI|XRAY: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple